BioFire COVID-19 Test 2— 510(k) K221460
Substantially EquivalentBiofire Defense, LLC
FDA 510(k) clearance K221460 for BioFire COVID-19 Test 2, Substantially Equivalent on 2022-07-25. Applicant: Biofire Defense, LLC.
Clearance details
- Applicant
- Biofire Defense, LLC
- Product code
- Code QQX
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Salt Lake City, UT, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.